D. Illescas

New Insights into Adjuvant Therapy for Localized Colon Cancer.

F. Ros Montañá, Nadia S González, D. G. Illescas, 2022, Hematology/oncology clinics of North America.

318O Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients

Carlo, Gennari, Provenzano, 2020, Annals of Oncology.

290P Potential enrichment strategies for next-generation sequencing (NGS) in primary brain cancers (pBCs) in a clinical series according to ESMO scale for clinical actionability of molecular targets (ESCAT)

O. Mirallas, E. Martínez-Sáez, F. Ros Montañá, 2022, Annals of Oncology.

741MO Luveltamab tazevibulin (STRO-002), an anti-folate receptor alpha (FolRα) antibody drug conjugate (ADC), demonstrates clinical activity in recurrent/progressive epithelial endometrial cancer (EEC): STRO-002-GM1 phase I dose expansion

D. Illescas, A. Oaknin, A. Gonzalez Martin, 2023, Annals of Oncology.